Indivior Pharmaceuticals, Inc. INDV Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's retained earnings?
- Indivior Pharmaceuticals, Inc. (INDV) reported retained earnings of -$280M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's retained earnings changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's retained earnings increased by 31.0% year-over-year, from -$406M to -$280M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's retained earnings?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's retained earnings has grown at a -8.1% compound annual growth rate (CAGR), from -$288M to -$243M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.